Abbott Molecular, Inc.
Abbott Park
Des Plaines
Illinois
60018-3315
United States
Tel: 224-361-7000
Fax: 224-361-7008
13 articles about Abbott Molecular, Inc.
-
FDA Approves Abbott Molecular, Inc. Test for Identifying Hepatitis C Genotypes
6/20/2013
-
BioGenex, Inc. and Abbott Molecular, Inc. Conclude Successful Partnership
3/4/2013
-
Abbott Molecular, Inc. Forms Pact With Janssen Biotech Inc. for Leukemia Test
2/21/2013
-
Abbott Laboratories and Merck & Co., Inc. Collaborate to Develop Companion Diagnostic Test for Investigational Cancer Therapy
3/6/2012
-
Abbott Molecular, Inc. Expands Agreement With GlaxoSmithKline to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer Immunotherapy Antigen
11/28/2011
-
Abbott Molecular, Inc.'s Genetic Test for Acute Myeloid Leukemia Prognosis Cleared by FDA
10/25/2011
-
China Department of Health Issues Recall for Abbott Molecular, Inc.'s Preparation System
10/14/2011
-
Abbott Molecular, Inc. Receives FDA Approval for ALK Gene Test for Lung Cancer Therapy Selection
8/29/2011
-
FDA Clears Abbott Molecular, Inc.'s Genetic FISH Panel for Leukemia Patient Prognosis
8/22/2011
-
Abbott Molecular, Inc.'s Ibis Technology Identified Fatal Disease Organism in Afghanistan
2/7/2011
-
Abbott Molecular, Inc. Receives FDA Approval for First Automated Molecular Test for Assessing Hepatitis B Treatment
9/1/2010
-
Epigenomics AG Announces Strategic In Vitro Diagnostics Partnership With Abbott Molecular, Inc.
9/26/2007
-
Enzo Biochem Announces Supply and Royalty Bearing Cross-Licensing Agreements with Abbott Molecular, Inc.
5/3/2007